CRISPR-Complete: End-to-end analytics of CRISPR/Cas9 experimental designs. Learn More.

Insight Into Your CRISPR/Cas9 Edits

With CRISPR-Complete™ Now!
Let's Get Started

CRISPR-Complete™ is defining the quality requirements to deliver unprecedented results when testing CRISPR/Cas9 edits. Our quality control solution offers industry-leading accuracy leading to a more streamlined and efficient workflow. CRISPR QC, utilizing the CRISPR-CHIP™, harnessed the technology, commercialized its use, and introduced efficient and successful quality control in the CRISPR/Cas9 genome editing process.

CRISPR-CHIP™ is known for its sensitivity and specificity for all major CRISPR/Cas9 applications. Internationally recognized, our CRISPR-CHIP™ was the cover story of the June 2019 issue of Nature biotechnology magazine. The article "Detection of unamplified target genes via CRISPR-Cas9 immobilized on a graphene field-effect transistor." was featured in over 30 news articles worldwide. 

 

Download Our Application Notes Today

Learn More about Our Technology

Biosignal Processing Unit™

Our technology, Powered by Cardea, is the first of its kind to do DNA testing without amplification or optics. Our success enables the stability of our platform to be used together with CRISPR/Cas9 and the ability to search genomes for data signals without the need for sequencing. 

CRISPR-Complete™

Eliminate the bottleneck in your CRISPR editing pipeline

1
Fast
CRISPR-CHIP™ was designed from the ground up to be a highly optimized and fast platform that can acquire CRISPR data at speeds faster than any other method – without any compromises.
2
Accurate
CRISPR-CHIP™ produces the highest possible accuracy for determining successful CRISPR edits because our BPU™ serves as a gateway between the live signals in biology and the digital world.
3
Flexible
CRISPR-Complete is a configurable platform designed to provide insight and data to scientists who seek to realize the full potential of CRISPR/Cas9 activity.

Schedule a Call With An Expert

CRISPR-Complete™ Solution

The Biggest Problem in CRISPR/Cas9 gene editing

CRISPR/Cas9 complexities often lead to increasing burdens on cost, risk, and extended or often delayed timelines. All of which can impact workflows and postpone or lead to error-prone results. Usually, a divergence in desired results leads to underperformance or multiple attempts in the quest for a successful edit.

CRISPR-Complete™ Solution

Incorporating our CRISPR-CHIP™ as the foundation of our CRISPR-Complete™ solution, we provide a process to assist knowledge seekers in understanding the relationship between gRNA design and interactions with Cas9 leading to the most active CRISPR complexes. Our capabilities include examining the interaction of CRISPR/Cas9 with amplicons and unamplified genomic DNA, which includes cutting (cleavage), often producing new and previously uncovered information that influences future designing of experiments for a better outcome at the cellular level. As a result, CRISPR-Complete™ delivers new learning insights, lowers the risk, and often shortens development timelines by providing relevant data for better gRNA selection and performance.